Skip to content

Medis Suite MRCT 2018

by Medis Medical Imaging Systems B.V.

Medis Suite MRCT 2018 is a medical device (FDA Class II; FDA product code LLZ, System, Image Processing, Radiological) made by Medis Medical Imaging Systems B.V., listed in FDA GUDID since 7 Aug 2018 (UDI-DI B141MEDISSUITEMRCT20180), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB141MEDISSUITEMRCT20180 UDI-DI Date7 Aug 2018ListedStatusListed GUDID: in commercial distribution

From the FDA record

Device description
Medis Suite MRCT is software intended to be used for the visualization and analysis of MR and CT images of the heart and blood vessels. Medis Suite MRCT is intended to support the following visualization functionalities: - cine loop and 2D review - double oblique review - 3D review by means of MIP and volume rendering - 3D reformatting - performing caliper measurements Medis Suite MRCT is also intended to support the following analyses: - cardiac function quantification - MR velocity-encoded flow quantification - anatomy and tissue segmentation - signal intensity analysis for the myocardium and infarct sizing - MR parametric maps (such as T1, T2, T2* relaxation) Medis Suite MRCT is also intended to be used for: - quantification of T2* results in MR images that can be used to characterize iron loading in the heart and the liver - MR velocity-encoded flow quantification of cerebral spinal fluid These analyses are based on contours that are either manually drawn by the clinician or trained medical technician who is operating the software, or automatically detected by the software and subsequently presented for review and manual editing. The results obtained are displayed on top of the images and provided in reports. The analysis results obtained with Medis Suite MRCT are intended for use by cardiologists and radiologists to support clinical decisions concerning the heart and vessels.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Medis Suite MRCT
Generic name
Laboratory instrument/analyser application software IVD
Model / reference
2018
Primary DI / UDI-DI
B141MEDISSUITEMRCT20180
FDA product code
LLZ
GMDN term
Laboratory instrument/analyser application software IVD
Device class
Class II
Regulation number
892.2050
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Laboratory instrument/analyser application software IVD.

Other devices from Medis Medical Imaging Systems, Inc.

See all devices from Medis Medical Imaging Systems, Inc. →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)